“I am honored to take the helm of Ventus and bring this level of protection to the market.” Said retired special ops soldier and now CEO, Arjun Grewal. “The TR2 is one of those pieces of equipment I wish I had in my bag 15 years ago. The more we learn about respiratory health, burn pits and toxic environments, the more I think about my own career. and away we have at Ventus addresses”

Ventus marks the first capital commitment of the recently launched ONE9 Special Mission Fund, which targets $50m focused on national security and critical infrastructure. “Protecting soldiers is a chain of command and a leadership responsibility,” said Glenn Cowan, who founded ONE9 after serving 18 years in the Canadian Forces. “Respiratory health is critical to a soldier’s performance, long-term health, and survivability. No product like this currently exists at soldier scale, and we know that the TR2 will save lives and improve the efficiency of training and operations, it’s time every soldier receives this protection to protect themselves against the daily dangers they face in their military service”

Ventus has expanded its reach by working with established leaders in defense protection to deliver a complete tactical protection ecosystem from the shoulders up. With the founder of Ventus, Rich Szaszand product manager, Norrie ShengVentus will bring the TR2 to market while developing and engineering advanced filtration and respirator innovations.

Ventus Respiratory Technologies is a veteran-led company. The flagship innovation, TR2, sets a new standard in tactical protection. The TR2 offers a low-profile, easy-to-carry design and integrates seamlessly into various soldier systems. The TR2 protects against airborne threats such as lead, asbestos and mold by filtering 97% of airborne solid particles down to 03 µm. Developed in conjunction with Level 1 Special Operations, it protects user health when training and operating in compromised and toxic environments. Ventus Respiratory Technologies keeps the air safe for those who protect us.

SOURCEVentus Respiratory Technologies


Comments are closed.